Figure 4 | Cell Death & Disease

Figure 4

From: Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma

Figure 4

Cezanne predicts response to postoperative TACE in several clinical subgroups. All patients were stratified according to Cezanne levels within vascular invasion (a and b), tumor size (c and d) or tumor number status (e and f). Kaplan–Meier survival estimates and log-rank tests were used to analyze the correlation between adjuvant TACE therapy and time to recurrence in clinical subgroups

Back to article page